Sort
27,075 grants matching “cholesterol”
Genetic analysis of sphingolipid metabolism and obesity
$225,000San Diego State University · R21 · FY2004 · HL
Filtration Media for In-Home PFAS Removal from Drinking Water
$225,000Steven D Dietz · Tda Research, Inc. · R43 · FY2021 · ES
Older Persons & Drugs: race, gender, and age effects
$225,000Janice B Schwartz · Jewish Home Of San Francisco · R56 · FY2010 · AG
Active Immunity Targeted at PCSK9 for the Treatment of Hypercholesterolemia
$225,000Ba-Bie Teng · University Of Texas Hlth Sci Ctr Houston · R21 · FY2012 · HL
Irreversible Inhibitors of Cholesterol Esterase
$225,000University Of New Mexico · R15 · FY2005 · HL
Nuclear receptor signaling in BACE1 gene repression under neuroinflammation
$225,000Francesca-Fang Liao · University Of Tennessee Health Sci Ctr · R21 · FY2013 · NS
Longtitudinal Study of Dialysis
$225,000Wen Hong Linda Kao · Johns Hopkins University · R56 · FY2012 · DK
SBIR Phase I: Converting Greek yogurt waste into a low-calorie natural sweetener
$225,000Kulika Chomvong · Zimitech, Inc. · · FY2016 · TIP
Sub-Clinical Coronary Artery Disease in South Asian Immigrants: Determination of
$225,000Sunita Dodani · University Of Kansas Medical Center · R15 · FY2008 · HL
Localized Statin Delivery for Prevention of Primary AV Fistula Failure
$225,000Sean T. Zuckerman · Affinity Therapeutics, Llc · R43 · FY2017 · HL
Breakthrough sub-cellular 3D chemical composition research platform for live cells, based on the new invention of nanoscale - confocal photothermal IR micro-spectroscopy (n-CPIR)
$225,000Ji-Xin Cheng · Anasys Instruments Corporation · R41 · FY2017 · CA
AD pathogenesis in a novel mouse diet model with a partial eNOS deficiency
$225,000Francesca-Fang Liao · University Of Tennessee Health Sci Ctr · R21 · FY2012 · AG
Catalytic inactivation of miRNA function by customized RNase P-based ribozymes
$225,000Daniel R. Schoenberg · Ohio State University · R21 · FY2009 · AI
GENE/DIET EFFECTS ON PLASMA LIPOPROTEIN LEVELS
$225,000Tufts University Boston · R01 · FY2001 · HL
Investigating modes of action of glyphosate-induced ovotoxicity
$225,000Aileen Frances Keating · Iowa State University · R21 · FY2016 · ES
HABIT DESIGN: TESTING A NOVEL BEHAVIORAL APPROACH TO CORPORATE WELLNESS IN THE CONTEXT OF METABOLIC SYNDROME
$224,991Michael Kim · Habit Design, Inc. · R44 · FY2019 · HL
Innovative Delivery of siRNA across the Blood Brain Barrier
$224,989Robert Sons · Fannin Partners, Llc · R43 · FY2018 · AG
AN OPEN WEB SERVICE FOR FRAGMENT-BASED DESIGN OF SMALL MOLECULE INHIBITORS
$224,972John L Kulp · Conifer Point Pharmaceuticals, Llc · R43 · FY2016 · GM
Balloon Angioplasty Inflation Device
$224,952Nick Rydberg · Minnesota Healthsolutions Corporation · R43 · FY2017 · AG
Role of Specific Drugs and Mutations in Partial Suppression of Viremia
$224,932Frank Maldarelli · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Hormone &Prostaglandin Regulation of StAR in the Ovary
$224,892University Of South Florida · R01 · FY2002 · HD
A Platform Technology for High-Throughput Screening of Gene Regulatory Elements
$224,881Gregory E Crawford · Element Genomics, Inc. · R41 · FY2016 · GM
A Comprehensive Assessment of Health Literacy and CVD-Related Outcomes
$224,869Laurie Thayer Martin · Rand Corporation · R21 · FY2010 · HL
Therapeutic and Diagnostic Factors as Related to Cancer Risk
$224,821Gretchen Gierach · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
TEMPORAL DIETARY PATTERNS: DEVELOPMENT AND EVALUATION AGAINST ADIPOSITY AND METABOLIC BIOMARKERS
$224,806Yikyung Park · Washington University · R01 · FY2021 · CA